new semaglutide injection A study conducted by leading researchers across the United States suggests GLP-1s could have a much greater impact beyond obesity. Follow the link in our bio for more on the study related medical problems Millions of Medicare beneficiaries to

It suggests that the NO system may be involved in the protective effect of BPC 157 on Clopidogrel-induced gastric mucosal injury

The relationship between psychotropic drug use and suicidal behavior in Japan: Japanese adverse drug event report

Mounjaro, a newer medication, combines a GLP-1 receptor agonist with a glucose-dependent insulinotropic polypeptide (GIP) agonist, offering a dual-action approach to enhance weight loss and glycemic control

This is why weight loss naturally slows over time even when youre doing everything right

Most users report significant hunger reduction at 0.5 mg, with further suppression at 1.0 mg

Join the Scientific Sessions conversation on social media using #ADASciSessions